To Heal Diabetic Foot Ulcers, A New Drug Harnesses Stem Cells Inside Us All : RushPRNews - Newswire & Global Press Release Distribution

Bookmark and Share

To Heal Diabetic Foot Ulcers, A New Drug Harnesses Stem Cells Inside Us All

November 12, 2009

Princeton, NJ (rushPRnews) 11/12/09 — Diabetic foot ulcers are the primary cause of hospital admissions for diabetics. Foot ulcers that heal improperly are at risk for infection, which can lead to amputation.  According to the American Diabetes Association, one in four patients with diabetic foot ulcers will eventually require lower-limb amputation.  Now science has found a way of mobilizing stem cells within the body to treat this health issue, which affects more than three million Americans annually.

Mesenchymal stem cells (MSCs), as distinct from the embryonic type, may be the key to healing diabetic foot ulcers.  These stem cells can differentiate into various cell types.  As a fetus develops, MSCs help drive its rapid initial growth; by the time we reach our teens, however, MSCs are mostly found in bone marrow.  

When wounded or burned, our skin craves MSCs, which it harbored when first growing.  In fact, recent studies show that surgically moving these cells from bone marrow onto hard-to-heal wounds accelerates healing.  

In contrast to surgically removing MSCs from bone marrow—a painful, time consuming and expensive process—a new topical drug, the novel angiotensin analog DSC127, appears to activate the mesenchymal stem cells in a patient’s body. 

“It appears that DSC127 directs MSCs to the injury site, mobilizing them to help repair wounded or burned skin, accelerate healing and reduce scar formation,” said Edward J. Quilty, Chairman & CEO of Derma Sciences Inc.  Based in Princeton, New Jersey, Derma Sciences develops, manufactures, and markets innovative wound care products.  “DSC127,” Quilty observed, “thus works as a catalyst for a stem cell treatment that is free of both the ethical controversies surrounding the medical use of fertilized embryos as well as potentially painful surgical interventions.”

Currently in a 75-patient Phase II diabetic foot ulcer clinical trial being conducted at some of the nation’s top institutions, the drug is being considered for additional indications including venous leg ulcers, arterial ulcers, pressure ulcers, thermal and chemical wounds, and scar prevention.  Pre-clinical animal studies have demonstrated the efficacy of the compound in accelerating healing and reducing scar formation. 

If DSC127 is approved for market, patients with diabetic foot ulcers may find a solution already exists within their own bodies.  For more information, visit

Media Contact Name: Janet Vasquez
Media Phone: 212-825-3210
Media Web Address:
Company Web Address:
About the author:

Janet Vasquez, Director of Corporate Communications

About IRG

We are The Investor Relations Group (IRG), a full-service corporate communications firm that provides investor relations and public relations services to nano-, micro- and small-cap companies providing them with the equivalent in-house services of a large-cap company.

Click here to see all news from this author/company

Filed Under: Article-byline, BREAKING NEWS, FDA- Pharmaceutical news

RUSH PR NEWS newswire and press release services at / AH Marketing

Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.

Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.

Rush PR News is not the contact for material published.


Newborn Foundation Hosts Annual Awards Gala

SAINT PAUL, MN 10/21/16 · U.S. Senator Amy Klobuchar honored: More than $220,000 raised...

Beyoncé and Destiny's Child Documentary Set to Premiere in Houston

Houston, Texas USA 10/15/16 · Making a Child of Destiny: The Andretta Tillman...

Far East Hospitality named Best Employer 2016 by Aon Hewitt

Singapore 10/13/16 · - Far East Hospitality, Singapore’s leading operator of...

Attorney Scott Glovsky Launches Trial Lawyer Talk, A New Legal Podcast

Pasadena, CA 10/13/16 ·  – Award-winning California trial attorney Scott Glovsky has...

Pre-Owned Mercedes Cars that are Worth Buying

Toronto, Canada 10/08/16 · Every car lover dreams of buying a Mercedes...

TryMyKitchen goes global as the first and best dedicated marketplace for booking cooking classes

London, UK 10/07/16 · offers an unrivalled service for people wishing...

Jafme Inc.: New Job Search App Brings New Opportunities

New York 10/07/16 · Jafme Inc. unveiled new mobile app to assist...

Rainwater Sustainable Alternative To Drilling Wells And Hauling Water

CRAIK, SK 10/07/16 · Local Company Says Canadians Can Conserve Water and...

Visionup Strobe Glasses

Tokyo, Japan 10/06/16 · The world’s 1st Strobe Glasses for young athletes Visionup...

Quality Roofing Contractors in Melbourne

AUSTRALIA 10/06/16 · A roof is part of a building’s exterior...

Utilization of Water Treatment Plant

Ahmedabad, Gujarat 10/06/16 · Water, a characteristic and fundamental asset is without...

New Dodge RAM 1500 Has All the Qualities of Becoming A Reliable Pickup Truck

Toronto, ON 10/06/16 · 2016 RAM 1500 is available with minor changes...


Winnipeg, MB 10/06/16 · The Comprehensive Wealth Indicator Report, coming spring 2016,...